Whitehawk Therapeutics, Inc. (WHWK) Stock
Whitehawk Therapeutics stock price chart
WHWK stock quote & key statistics
Whitehawk Therapeutics annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $7.1M | -$20.6M | -$1.71 |
| FY2024 | $26.0M | -$63.7M | -$2.26 |
| FY2023 | $24.4M | -$65.8M | -$2.44 |
| FY2022 | $15.2M | -$60.5M | -$2.51 |
| FY2021 | $1.1M | -$110.1M | -$3.63 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Whitehawk Therapeutics stock FAQ
What is the Whitehawk Therapeutics stock ticker symbol?
Whitehawk Therapeutics, Inc. trades on the NASDAQ under the ticker symbol WHWK.
What sector and industry is Whitehawk Therapeutics in?
Whitehawk Therapeutics, Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Whitehawk Therapeutics have?
Whitehawk Therapeutics, Inc. has about 32 full-time employees.
What were Whitehawk Therapeutics's revenue and earnings last fiscal year?
Whitehawk Therapeutics reported revenue of $7.1M and net income of -$20.6M in fiscal 2025, with earnings per share of -$1.71. Revenue declined 72.5% from the prior year.
Is Whitehawk Therapeutics in the Russell 2000?
Yes. Whitehawk Therapeutics, Inc. (WHWK) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Whitehawk Therapeutics go public?
Whitehawk Therapeutics stock began trading on August 8, 2017.
Russell 2000 Biotechnology stocks
All Russell 2000 →- CGONCG Oncology
- COGTCogent Biosciences
- CRSPCRISPR Therapeutics
- CYTKCytokinetics
- DFTXDefinium Therapeutics
- DNTHDianthus Therapeutics
- IBRXImmunityBio
- IOVAIovance Biotherapeutics
- KODKodiak Sciences
- KRYSKrystal Biotech
- KYMRKymera Therapeutics
- LGNDLigand Pharmaceuticals
- MIRMMirum Pharmaceuticals
- ORKAOruka Therapeutics
- PCVXVaxcyte
- PRAXPraxis Precision Medicines
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- RYTMRhythm Pharmaceuticals
- SRRKScholar Rock
- SYRESpyre Therapeutics
- TGTXTG Therapeutics
- TVTXTravere Therapeutics
- TWSTTwist Bioscience